![]() BenevolentAI BenevolentAI is a company that develops artificial intelligence and machine learning technologies for drug discovery and life sciences. | ![]() Keros Therapeutics Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta. | ![]() Strand Therapeutics Strand Therapeutics is a company that develops mRNA-based therapeutics with programmable genetic circuits. | |
Founding Date | Founding Date 2013 | Founding Date 2015 | Founding Date 2017 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations London, GB HQ Babraham, GB | Locations Lexington, US HQ South Wharf, AU | Locations Boston, US HQ |
Employees | Employees 180 | Employees 7854% decrease | Employees 12119% increase |
Valuation ($) | Valuation ($) 1 b | Valuation ($) 2.3 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) €7.3m (FY, 2023) | Revenue (est.) $244.1m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income (€63.3m) (FY, 2023) | Net income $87m (FY, 2025) | Net income N/A |
Funding | |||
Latest funding round | Latest funding round $ 90m (almost 7 years ago) | Latest funding round N/A | Latest funding round $ 45m (over 3 years ago) |
Total funding raised | Total funding raised $ 305m | Total funding raised $ 90m | Total funding raised $ 6m |

Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta.
View company
Strand Therapeutics is a company that develops mRNA-based therapeutics with programmable genetic circuits.
View company